Mavenome and Growth VCT 3 (LSE:MIG3) Research & Development: £0.00 Mil (TTM As of Nov. 2025)


LSE:MIG3 Maven Income and Growth VCT 3 PLC LSE:MIG3
30 GF Score
Price £0.42
! 5 Warning Signs
View Full Analysis

What is Mavenome and Growth VCT 3 Research & Development?

Mavenome and Growth VCT 3 LSE:MIG3 -3.20% 30 Research & Development is £0.00 Mil as of Nov. 2025. GuruFocus rates LSE:MIG3 with a GF Score™ of 30/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Mavenome and Growth VCT 3's Research & Development for the six months ended in Nov. 2025 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 was £0.00 Mil.

Mavenome and Growth VCT 3  (LSE:MIG3) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mavenome and Growth VCT 3 Research & Development Related Terms

Mavenome and Growth VCT 3 Research & Development Historical Data

* Premium members only.

The historical data trend for Mavenome and Growth VCT 3's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mavenome and Growth VCT 3 Research & Development Chart

Mavenome and Growth VCT 3 Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Mavenome and Growth VCT 3 Semi-Annual Data
May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:MIG3
30GF Score
Maven Income and Growth VCT 3 PLC LSE:MIG3
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mavenome and Growth VCT 3 Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.00 Mil mean?
Mavenome and Growth VCT 3 (LSE:MIG3) has a Research & Development of £0.00 Mil as of Nov. 2025. Research and development expense is the total cost for research and development activities. View historical data on Mavenome and Growth VCT 3 and its competitors.
Is Mavenome and Growth VCT 3's Research & Development too high?
Mavenome and Growth VCT 3's current Research & Development is £0.00 Mil. Overall, Mavenome and Growth VCT 3 has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Mavenome and Growth VCT 3's Research & Development compare to BLK and BX?
Mavenome and Growth VCT 3's Research & Development of £0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Mavenome and Growth VCT 3 and its competitors. Mavenome and Growth VCT 3's current Research & Development is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mavenome and Growth VCT 3 stock overvalued right now?
Mavenome and Growth VCT 3 (LSE:MIG3) has a current Research & Development of £0.00 Mil. The current Research & Development is £0.00 Mil. Mavenome and Growth VCT 3's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Mavenome and Growth VCT 3 (LSE:MIG3), the current Research & Development is £0.00 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mavenome and Growth VCT 3 Business Description

Address 205 West George Street, Kintyre House, Glasgow, GBR, G2 2LW
Maven Income and Growth VCT 3 PLC is a Venture Capital Trust (VCT). Its investment objective is to achieve long-term capital appreciation and generate income for shareholders. The company invests the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM-quoted companies that meet the criteria for VCT qualifying investments and have growth potential. Its investment portfolio comprises companies from various sectors such as software and technology, business services, industrials and engineering, learning and development, recruitment technology, pharmaceuticals, etc.
30GF Score

Get the complete analysis for LSE:MIG3

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.42
Price